These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12606129)

  • 1. Combined cytogenetic and array-based comparative genomic hybridization analyses of Wilms tumors: amplification and overexpression of the multidrug resistance associated protein 1 gene (MRP1) in a metachronous tumor.
    Goldstein M; Rennert H; Bar-Shira A; Burstein Y; Yaron Y; Orr-Urtreger A
    Cancer Genet Cytogenet; 2003 Mar; 141(2):120-7. PubMed ID: 12606129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors.
    Schaub R; Burger A; Bausch D; Niggli FK; Schäfer BW; Betts DR
    Cancer Genet Cytogenet; 2007 Jan; 172(1):61-5. PubMed ID: 17175381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.
    Hontecillas-Prieto L; Garcia-Dominguez DJ; Vaca DP; Garcia-Mejias R; Marcilla D; Ramirez-Villar GL; Saez C; de Álava E
    Oncotarget; 2017 Feb; 8(7):11173-11186. PubMed ID: 28061436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of limited regions of genetic aberrations in patients affected with Wilms' tumor using a tiling-path chromosome 22 array.
    Benetkiewicz M; Díaz de Ståhl T; Gördör A; Pfeifer S; Wittmann S; Gessler M; Dumanski JP
    Int J Cancer; 2006 Aug; 119(3):571-8. PubMed ID: 16496407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for submicroscopic chromosomal rearrangements in Wilms tumor using whole-genome microarrays.
    Rassekh SR; Chan S; Harvard C; Dix D; Qiao Y; Rajcan-Separovic E
    Cancer Genet Cytogenet; 2008 Apr; 182(2):84-94. PubMed ID: 18406869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution molecular cytogenetic analysis of Wilms tumors highlights diagnostic difficulties among small round cell kidney tumors.
    Stewénius Y; Jin Y; Ora I; Panagopoulos I; Möller E; Mertens F; Sandstedt B; Alumets J; Akerman M; Merks JH; de Kraker J; Gisselsson D
    Genes Chromosomes Cancer; 2008 Oct; 47(10):845-52. PubMed ID: 18615675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences.
    Spreafico F; Ciceri S; Gamba B; Torri F; Terenziani M; Collini P; Macciardi F; Radice P; Perotti D
    Oncotarget; 2016 Feb; 7(8):8908-15. PubMed ID: 26802027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
    Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ
    Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomic hybridization analysis of Wilms tumors.
    Steenman M; Redeker B; de Meulemeester M; Wiesmeijer K; Voûte PA; Westerveld A; Slater R; Mannens M
    Cytogenet Cell Genet; 1997; 77(3-4):296-303. PubMed ID: 9284942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomic hybridization of Wilms' tumor.
    Rassekh SR; Rajcan-Separovic E
    Methods Mol Biol; 2013; 973():249-65. PubMed ID: 23412795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Array CGH Analysis of Paired Blood and Tumor Samples from Patients with Sporadic Wilms Tumor.
    Cabral de Almeida Cardoso L; Rodriguez-Laguna L; Del Carmen Crespo M; Vallespín E; Palomares-Bralo M; Martin-Arenas R; Rueda-Arenas I; Silvestre de Faria PA; ; García-Miguel P; Lapunzina P; Regla Vargas F; Seuanez HN; Martínez-Glez V
    PLoS One; 2015; 10(8):e0136812. PubMed ID: 26317783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.
    Chiang MR; Kuo CW; Wang WC; Hou TC; Kuo CY; Lu MY; Lai YC
    Pathol Oncol Res; 2019 Jul; 25(3):1199-1206. PubMed ID: 30671724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumors.
    Vuononvirta R; Sebire NJ; Dallosso AR; Reis-Filho JS; Williams RD; Mackay A; Fenwick K; Grigoriadis A; Ashworth A; Pritchard-Jones K; Brown KW; Vujanic GM; Jones C
    Clin Cancer Res; 2008 Dec; 14(23):7635-44. PubMed ID: 19047088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the multidrug resistance-related protein MRP1 in the histological compartments of nephroblastomas.
    Efferth T; Thelen P; Schulten HG; Bode ME; Granzen B; Beniers AJ; Mertens R; Ringert RH; Gefeller O; Jakse G; Fuzesi L
    Int J Oncol; 2001 Aug; 19(2):367-71. PubMed ID: 11445853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
    Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
    Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
    Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
    Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined BubR1 protein down-regulation and RASSF1A hypermethylation in Wilms tumors with diverse cytogenetic changes.
    Haruta M; Matsumoto Y; Izumi H; Watanabe N; Fukuzawa M; Matsuura S; Kaneko Y
    Mol Carcinog; 2008 Sep; 47(9):660-6. PubMed ID: 18286482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification and expression of EGFR and ERBB2 in Wilms tumor.
    Vasei M; Modjtahedi H; Ale-Booyeh O; Mosallaei A; Kajbafzadeh AM; Shahriari M; Ghaderi AA; Soleymanpour H; Kosari F; Moch H; Sauter G
    Cancer Genet Cytogenet; 2009 Oct; 194(2):88-95. PubMed ID: 19781441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.